GO:1903775 regulation of DNA double-strand break processing: DNA Repair Pathway Choice, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903775 describes any process that modulates the frequency, rate or extent of DNA double-strand break processing, the nucleolytic and chromatin-driven steps that commit a break to a specific repair pathway.
• DNA end resection is the decisive processing step: it removes 5' strands to create 3' single-stranded DNA, promoting homologous recombination and suppressing non-homologous end joining.
• BRCA1-BARD1 directly promotes DNA end resection, whereas 53BP1 and its effectors antagonize resection and favor error-prone rejoining.
• Regulation of processing is achieved through post-translational modification, chromatin remodeling, and cell-cycle-dependent recruitment of resection factors.
• Defects in double-strand break processing regulation cause genome instability, radiosensitivity, and are exploited in cancer therapy.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of processing regulators in repair pathway choice.
Description
DNA double-strand breaks (DSBs) are among the most cytotoxic lesions a cell can encounter, and their repair must be tightly regulated to preserve genome integrity. The biological process GO:1903775, regulation of DNA double-strand break processing, encompasses all mechanisms that modulate the frequency, rate, or extent of the nucleolytic and structural processing events that occur at DSB ends. This regulation is critical because the initial processing step, DNA end resection, determines whether a break is repaired by homologous recombination (HR) or by non-homologous end joining (NHEJ). Researchers studying genome stability, cancer biology, and CRISPR-based genome editing need a precise understanding of this term because misregulation of DSB processing drives mutagenesis, therapy resistance, and developmental defects. The QuickGO definition of GO:1903775 is intentionally broad: it includes any process that modulates DSB processing, such as protein recruitment, post-translational modifications, and chromatin changes that influence resection. This article integrates authoritative QuickGO annotation with verified PubMed literature to provide a research-grade overview of the genes, mechanisms, and experimental models used to study this process.
regulation of DNA double-strand break processing At A Glance
| GO ID | GO:1903775 |
|---|---|
| GO term | regulation of DNA double-strand break processing |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of DNA double-strand break processing, including DNA end resection and repair pathway choice |
| Key positive regulators | BRCA1-BARD1 complex promotes resection |
| Key negative regulators | 53BP1 and its downstream effectors antagonize resection |
| Post-translational regulation | Crotonylation of DNA-PKcs by GCN5 influences DSB repair |
| Cell-cycle dependence | Resection is restricted to S/G2 phases to ensure sister-chromatid availability |
What Is GO:1903775?
GO:1903775, regulation of DNA double-strand break processing, is defined by QuickGO as any process that modulates the frequency, rate or extent of DNA double-strand break processing. In practice, this means the cellular control of the enzymatic and structural steps that convert a broken DNA end into a substrate for a specific repair pathway, most notably the regulation of DNA end resection. It is a biological_process term that sits upstream of the actual processing reactions and includes both positive and negative regulation.
Why Is regulation of DNA double-strand break processing Important in Cell Biology?
Regulation of DNA double-strand break processing is central to genome stability because it dictates repair pathway choice, and errors in this decision lead to mutations, chromosomal rearrangements, and cell death. Understanding GO:1903775 helps researchers interpret how cells balance high-fidelity HR against error-prone NHEJ, a balance that is frequently disrupted in cancer and in inherited disorders. Moreover, this process is directly relevant to CRISPR genome editing, where the processing of Cas9-induced breaks determines editing outcomes.
• Determines whether a DSB is repaired by homologous recombination or non-homologous end joining.
• Controls genome stability and prevents chromosomal translocations.
• Influences sensitivity to radiotherapy and DNA-damaging chemotherapy.
• Is frequently deregulated in breast, ovarian, and other cancers with BRCA1/2 mutations.
• Affects the efficiency and precision of CRISPR-Cas9 genome editing.
• Plays a role in meiotic DSB formation and processing in mammals.
• Involves chromatin remodeling and nuclear dynamics that facilitate repair.
• Provides targets for synthetic lethality strategies in cancer therapy.
• Is essential for lymphocyte development and immune diversity.
• Underpins the interpretation of genetic screens for DNA repair factors.
What Happens During regulation of DNA double-strand break processing?
Initiation of DNA end resection
In simple terms: The cell starts chewing back the broken DNA ends to create single-stranded tails.
DNA end resection is the first committed step of DSB processing, generating 3' single-stranded DNA (ssDNA) that is bound by RPA and later by RAD51. This step is tightly regulated because it commits the break to homologous recombination and prevents non-homologous end joining. The MRN complex (MRE11-RAD50-NBS1) and CtIP initiate short-range resection, which is then extended by EXO1 and BLM/DNA2. Regulation of this initiation is critical for pathway choice and is influenced by cell cycle and chromatin context.
Positive regulation by BRCA1-BARD1
In simple terms: BRCA1-BARD1 acts as a green light for resection, helping the cell choose accurate repair.
The BRCA1-BARD1 complex directly promotes DNA end resection and homologous recombination. It counteracts the resection-inhibitory activity of 53BP1 and its effectors, thereby shifting the balance toward HR. Loss of BRCA1 or BARD1 leads to defective resection, impaired HR, and sensitivity to PARP inhibitors. This regulation is essential for maintaining genome integrity in proliferating cells.
Negative regulation by 53BP1 and its effectors
In simple terms: 53BP1 acts as a brake on resection, favoring a faster but less accurate repair.
53BP1 binds to chromatin around DSBs and inhibits DNA end resection, promoting non-homologous end joining. It recruits downstream effectors such as RIF1 and the Shieldin complex to block resection. This negative regulation is important for class switch recombination in B cells but can also drive error-prone repair and genome instability. The balance between 53BP1 and BRCA1 determines repair pathway choice.
Post-translational modifications and chromatin regulation
In simple terms: Chemical tags on proteins and changes to DNA packaging help control when and where processing happens.
Post-translational modifications, such as crotonylation of DNA-PKcs by GCN5, regulate DSB repair and influence radiosensitivity. Chromatin remodeling and histone modifications also modulate the accessibility of DSB ends to processing enzymes. These modifications provide additional layers of regulation that fine-tune the frequency and extent of DSB processing.
Cell-cycle and nuclear dynamics
In simple terms: The cell only allows certain types of processing at specific times and locations in the nucleus.
DNA end resection is restricted to the S and G2 phases of the cell cycle, when sister chromatids are available for homologous recombination. Nuclear and genome dynamics, including movement of damaged loci to specific nuclear compartments, also influence DSB processing. This spatial and temporal regulation ensures that processing is coordinated with other cellular events.
Key Genes Involved in GO:1903775 regulation of DNA double-strand break processing
The following genes and proteins are central to the regulation of DNA double-strand break processing, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BRCA1 | Promotes DNA end resection and homologous recombination | Key tumor suppressor; target for PARP inhibitor therapy |
| BARD1 | Partners with BRCA1 to promote resection | Mutations linked to breast and ovarian cancer |
| TP53BP1 | Inhibits DNA end resection and promotes NHEJ | Determines repair pathway choice; biomarker for therapy response |
| RIF1 | Effector of 53BP1 that blocks resection | Regulates NHEJ and class switch recombination |
| MRE11 | Component of MRN complex; initiates resection | Mutations cause ataxia-telangiectasia-like disorder |
| RAD50 | Component of MRN complex; holds DNA ends | Defects lead to genome instability |
| NBN | Component of MRN complex; recruits ATM | Mutations cause Nijmegen breakage syndrome |
| CTIP | Promotes short-range resection | Regulates pathway choice; frequently overexpressed in cancer |
| EXO1 | Long-range resection nuclease | Influences resection length and HR efficiency |
| BLM | Helicase that promotes resection | Mutations cause Bloom syndrome |
| DNA2 | Nuclease that promotes resection | Works with BLM for long-range resection |
| DNA-PKcs | Kinase involved in NHEJ; regulated by crotonylation | Target for radiosensitization |
| GCN5 | Acetyltransferase that crotonylates DNA-PKcs | Modulates DNA repair and radiosensitivity |
| ATM | Master kinase that coordinates DSB response | Mutations cause ataxia-telangiectasia |
| RAD51 | Forms nucleoprotein filament on ssDNA for HR | Key HR effector; target for cancer therapy |
| RPA | Binds ssDNA during resection | Essential for resection and HR |
| H2AX | Histone variant phosphorylated at DSBs | Marker of DSB formation and repair |
How Is regulation of DNA double-strand break processing Regulated?
Regulation of DNA double-strand break processing is achieved through multiple layers, including cell-cycle-dependent expression and phosphorylation of resection factors, post-translational modifications such as crotonylation, and chromatin remodeling. The balance between BRCA1-BARD1 and 53BP1 is a central regulatory node that determines pathway choice. Additionally, meiotic DSB formation and processing are regulated by developmental and tissue-specific factors.
regulation of DNA double-strand break processing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BRCA1 | Hereditary breast and ovarian cancer; defective HR | BRCA1 knockout or point-mutation cell lines |
| TP53BP1 | Therapy resistance; altered pathway choice | 53BP1 knockout and overexpression models |
| MRE11 | Ataxia-telangiectasia-like disorder | MRE11 knockout or knock-in of patient mutations |
| NBN | Nijmegen breakage syndrome | NBN knockout and complemented cell lines |
| DNA-PKcs | Radiosensitivity; NHEJ defects | DNA-PKcs point-mutation and overexpression models |
Cancer and therapy resistance
Deregulation of DSB processing is a hallmark of cancer. BRCA1 and BARD1 mutations impair resection and HR, leading to sensitivity to PARP inhibitors and platinum-based chemotherapy. Conversely, overexpression of 53BP1 or loss of BRCA1 can shift repair toward error-prone NHEJ, causing genome instability and therapy resistance. GCN5-mediated crotonylation of DNA-PKcs influences radiosensitivity, making it a potential target for radiosensitization.
Neurodegeneration and developmental disorders
Inherited mutations in MRN complex components (MRE11, RAD50, NBN) cause rare neurodegenerative and developmental disorders such as ataxia-telangiectasia-like disorder and Nijmegen breakage syndrome, characterized by genome instability and radiosensitivity. Defective DSB processing during meiosis can also lead to infertility and developmental defects.
Genome editing outcomes
The regulation of DSB processing directly impacts CRISPR-Cas9 genome editing. The choice between HR and NHEJ determines whether precise edits or insertions/deletions are generated. Understanding the genetic landscape of DSB repair can guide the design of more efficient and precise editing strategies.
From regulation of DNA double-strand break processing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of BRCA1 impair DNA end resection? | BRCA1 knockout cell line |
| Does a specific point mutation in DNA-PKcs affect radiosensitivity? | DNA-PKcs point-mutation knock-in |
| How does 53BP1 overexpression alter repair pathway choice? | 53BP1 overexpression cell model |
| Can a tagged resection factor be used to monitor dynamics? | Endogenous knock-in of fluorescent tag |
| Which genes regulate DSB processing in a genome-wide manner? | CRISPR library screening |
| Does a disease-associated mutation in MRE11 affect resection? | MRE11 knock-in of patient mutation |
How to Study the regulation of DNA double-strand break processing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Genes affecting DSB repair pathway choice | Discovery of novel regulators |
| Live-cell imaging | Recruitment kinetics of repair factors | Spatiotemporal regulation |
| In vitro resection assay | Nucleolytic processing of DNA ends | Biochemical mechanism |
| Mass spectrometry | Post-translational modifications on repair proteins | Regulation by crotonylation |
| Chromatin immunoprecipitation (ChIP) | Binding of factors to DSB sites | Pathway choice |
| Comet assay | DSB induction and repair kinetics | Genome stability assessment |
| RNA-seq | Transcriptional changes after DNA damage | Gene expression profiling |
| Meiotic DSB mapping | Genome-wide DSB hotspots | Meiotic recombination studies |
CRISPR screens for DSB repair factors
Genome-wide CRISPR knockout screens have been used to map the genetic landscape of DNA double-strand break repair, identifying novel regulators of processing and pathway choice. These screens typically use reporter systems that distinguish HR from NHEJ, enabling high-throughput discovery.
Imaging and single-molecule analysis
Advanced imaging techniques, including live-cell fluorescence microscopy and single-molecule tracking, allow researchers to visualize the recruitment and dynamics of processing factors at DSBs. These methods reveal spatial and temporal regulation of resection.
Biochemical assays for resection
In vitro resection assays using purified proteins or cell extracts measure the nucleolytic processing of DNA ends. These assays can be coupled with Western blotting for phosphorylated RPA or RAD51 to quantify resection.
Proteomics and post-translational modification analysis
Mass spectrometry-based proteomics can identify post-translational modifications, such as crotonylation, on DNA repair proteins like DNA-PKcs. This approach helps dissect how modifications regulate DSB processing.
How CRISPR Can Be Used to Study GO:1903775 regulation of DNA double-strand break processing
Knockout
CRISPR knockout of genes such as BRCA1, 53BP1, or MRE11 is used to determine their causal role in regulating DSB processing. Knockout cell lines can be challenged with DNA-damaging agents to assess sensitivity and repair efficiency.
Point Mutation
Point mutations can be introduced to model patient-derived missense variants or to ablate specific phosphorylation sites, allowing precise structure-function analysis of processing regulators.
Knock-in
Knock-in of fluorescent or epitope tags at endogenous loci enables real-time tracking of resection factors and their dynamics at DSBs. Knock-in of disease-associated mutations can recapitulate pathological phenotypes.
Overexpression
Overexpression of 53BP1 or other regulators can shift the balance of repair pathway choice, providing insights into how elevated levels contribute to therapy resistance.
How EDITGENE Supports regulation of DNA double-strand break processing Research
Researchers studying regulation of DNA double-strand break processing-related genes often need to determine whether a candidate gene is causally involved in resection, pathway choice, or genome stability. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for regulation of DNA double-strand break processing research.
Frequently Asked Questions About regulation of DNA double-strand break processing
What is GO:1903775?
GO:1903775 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of DNA double-strand break processing.
What genes are involved in regulation of DNA double-strand break processing?
Key genes include BRCA1, BARD1, TP53BP1, MRE11, RAD50, NBN, CTIP, EXO1, BLM, DNA2, DNA-PKcs, GCN5, ATM, RAD51, RPA, and H2AX.
How does BRCA1 regulate DNA end resection?
BRCA1-BARD1 directly promotes DNA end resection and homologous recombination, counteracting 53BP1-mediated inhibition.
What is the role of 53BP1 in DSB processing?
53BP1 inhibits DNA end resection and promotes non-homologous end joining, thereby influencing repair pathway choice.
How is DNA double-strand break processing regulated by post-translational modifications?
Crotonylation of DNA-PKcs by GCN5 regulates DSB repair and radiosensitivity.
Why is regulation of DSB processing important for cancer therapy?
Defects in this process cause sensitivity to PARP inhibitors and radiotherapy, while alterations can lead to therapy resistance.
What experimental models are used to study GO:1903775?
CRISPR knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR screens, are commonly used.
How does cell cycle affect DNA end resection?
Resection is restricted to S and G2 phases to ensure sister chromatid availability for homologous recombination.
What diseases are linked to defects in DSB processing regulation?
Cancer, neurodegeneration, and developmental disorders such as Nijmegen breakage syndrome and ataxia-telangiectasia-like disorder.
How can CRISPR screens help identify regulators of DSB processing?
Genome-wide CRISPR screens map the genetic landscape of DSB repair and identify novel regulators of processing and pathway choice.
Conclusion
GO:1903775, regulation of DNA double-strand break processing, is a critical biological process that governs repair pathway choice and genome stability. Its dysregulation underlies cancer, neurodegeneration, and developmental disorders, and it directly impacts CRISPR genome editing outcomes. Continued research using advanced CRISPR models and screening technologies will further illuminate the regulatory networks controlling DSB processing.
References
- 1. Hussmann JA et al.. 2021. Mapping the genetic landscape of DNA double-strand break repair.. Cell 184(22):5653-5669.e25 PMID: 34672952
- 2. Chiolo I et al.. 2025. Nuclear and genome dynamics underlying DNA double-strand break repair.. Nat Rev Mol Cell Biol 26(7):538-557 PMID: 40097581
- 3. Hanscom T et al.. 2020. Regulation of Error-Prone DNA Double-Strand Break Repair and Its Impact on Genome Evolution.. Cells 9(7) PMID: 32660124
- 4. Symington LS et al.. 2011. Double-strand break end resection and repair pathway choice.. Annu Rev Genet 45:247-71 PMID: 21910633
- 5. Salunkhe S et al.. 2024. Promotion of DNA end resection by BRCA1-BARD1 in homologous recombination.. Nature 634(8033):482-491 PMID: 39261729
- 6. Gupta A et al.. 2014. Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice.. Radiat Res 181(1):1-8 PMID: 24320053
- 7. Han Y et al.. 2024. GCN5 mediates DNA-PKcs crotonylation for DNA double-strand break repair and determining cancer radiosensitivity.. Br J Cancer 130(10):1621-1634 PMID: 38575732
- 8. Tang X et al.. 2026. Mechanism and regulation of meiotic double-strand break formation in mammals.. Trends Biochem Sci 51(4):354-366 PMID: 41850994
